Strategic Focus Target Europe-based precision diagnostic solutions for PET imaging with a strong emphasis on oncology and expanding into neurology to capture growing demand for molecular imaging therapies.

Financial Momentum Lean but proven financials with revenue in the tens of millions and substantial funding indicate capacity for early-stage partnerships, joint development, or selective licensing deals to accelerate product reach.

Partnership Network Existing collaborations across academia and healthcare institutions (e.g., Siriraj Mahidol collaboration) suggest opportunities for co-development, clinical trials support, and regional distribution agreements within Southeast Asia and Europe.

Digital Readiness Adoption of modern tech stack (Salesforce, HubSpot, Marketo, Magento, Sentry) enables scalable customer engagement, targeted marketing campaigns, and streamlined sales enablement for radiopharmaceutical products.

Growth Levers Rising corporate performance of parent group and global expansion activities create openings for new radiopharmaceutical supply agreements, manufacturing capacity expansion, and multi-country regulatory market access partnerships.